Adipose tissue concentrations of persistent organic pollutants and the risk of prostate cancer

Journal of Occupational and Environmental Medicine

Volumn 48, Issue 7, 2006, Pages 700-707

  Hardell, Lennart ^a,b   Andersson, Swen Olof ^a   Carlberg, Michael ^a   Bohr, Louise ^a   Van Bavel, Bert ^b   Lindström, Gunilla ^b   Björnfoth, Helen ^b   Ginman, Claes ^c  

^a ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^b ÖREBRO UNIVERSITY   (Sweden)

^c Department of Oncology   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

1,1 DICHLORO 2,2 BIS(4 CHLOROPHENYL)ETHYLENE; CHLORDANE; ENDOCRINE DISRUPTOR; HEPTACHLOR EPOXIDE; HEXACHLOROBENZENE; OXYCHLORDANE; PHENOBARBITAL; POLYCHLORINATED BIPHENYL; PROSTATE SPECIFIC ANTIGEN;

ADIPOSE TISSUE; ADULT; AGED; ARTICLE; CANCER RISK; CHLORINATION; CONFIDENCE INTERVAL; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MALE; MATERIALS; ORGANIC POLLUTION; POLLUTANT; PROSTATE CANCER; PROSTATE HYPERTROPHY; QUANTUM YIELD; STATISTICAL ANALYSIS;

ADIPOSE TISSUE; AGED; AGED, 80 AND OVER; HUMANS; MALE; MIDDLE AGED; OCCUPATIONAL EXPOSURE; POLYCHLORINATED BIPHENYLS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; RISK ASSESSMENT; STATE MEDICINE; SWEDEN;

EID: 33746368392     PISSN: 10762752     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jom.0000205989.46603.43     Document Type: Article

References (29)

1. Hsing AW, Tsao L, Devesa SS. International trends and patterns of prostate cancer incidence and mortality. Int J Cancer. 2000;85:60-67.
2. Crawford ED. Epidemiology of prostate cancer. Urology. 2003;62:3-12.
3. National Board of Health and Welfare. Cancer Incidence in Sweden 2003. Stockholm, Sweden. 2005. Available at: www.sos.se/sos/statisti.htm. Assessed February 1, 2006.
4. Fleming LE, Bean JA, Rudolph M, Hamilton K. Cancer incidence in a cohort of licensed pesticide applicators in Florida. J Occup Environ Med. 1999;41:279-288.
5. Burmeister LF, Everett GD, Van Lier SF, Isacson P. Selected cancer mortality and farm practices in Iowa. Am J Epidemiol. 1983;118:72-77.
6. Morrison H, Savitz D, Semenciw R, et al. Farming and prostate cancer mortality. Am J Epidemiol. 1993;137:270-280.
7. Parker AS, Cerham JR, Putnam SD, Cantor KP, Lynch CF. A cohort study of farming and risk of prostate cancer. Epidemiology. 1999;10:452-455.
8. Ritchie JM, Vial SL, Fuortes LJ, Guo H, Reedy VE, Smith EM. Organochlorines and risk of prostate cancer. J Occup Environ Med. 2003;45:692-702.
9. Ritchie JM, Vial SL, Fuortes LJ, et al. Comparison of proposed frameworks for grouping of polychlorinated biphenyl congener data applied to a case-control pilot study of prostate cancer. Environ Res. 2005;98:104-113.
10. Rothman N, Cantor KP, Blair A, et al. A nested case-control study on non-Hodgkin lymphoma and serum organochlorine residues. Lancet. 1997;350:240-244.
11. Hardell L, Eriksson M, Lindström G, et al. Case-control study on concentrations of organohalogen compounds and titers of antibodies to Epstein-Barr virus in the etiology of non-Hodgkin lymphoma. Leuk Lymphoma. 2001;42:619-629.
12. Hardell L, Eriksson M. Is the decline of the increasing incidence of non-Hodgkin lymphoma in Sweden and other countries a result of cancer preventive measures? Environ Health Perspect. 2003;111:1704-1706.
13. Safe SH. Toxiciology, structure-function relationship, and human and environmental health impacts of polychlorianted biphenyls: progress and problems. Environ Health Perspect. 1993;100:259-268.
14. Safe SH. Polychlorinated biphenyls (PCBs): environmental impact, biochemical and toxic responses, and implications for risk assessment. Crit Rev Toxicol. 1994;24:87-149.
15. Toppari J, Larsen JC, Christiansen P, et al. Male reproductive health and environmental xenstrogens. Environ Health Perspect. 1996;104:741-803.
16. Sonnenschein C, Soto AM. An updated review of environmental estrogen and androgen mimics and antagonists. J Steroid Biochem Mol Biol. 1998;65:143-150.
17. Coffey DS, Isaacs JT. Prostate tumor biology and cell kinetics - theory. Urology. 1981;17(Suppl 3):40-53.
18. Lindström G, van Bavel B, Järemo M, Karlsson L, Rappe C, Hardell L. The use of supercritical fluid extraction (SFE) as a sample preparation method in the analysis of PCDD, PCDF and PCB in human tissue. Organohalogen Compounds. 1995;23:27-30.
19. Wolff MS, Camann D, Gammon M, Stellman SD. Proposed PCB congener group-ings for epidemiological studies. Environ Health Perspect. 1997;105:13-14.
20. Moysich KB, Mendola P, Schisterman EF, et al. An evaluation of proposed frameworks for grouping polychlorinated biphenyl (PCB) congener data in meaningful units. Am J Ind Med. 1999;35:223-231.
21. McFarland VA, Clarke JU. Environmental occurrence, abundance, and potential toxicity of polychlorinated biphenyl congeners: considerations for a congener-specific analysis. Environ Health Persp. 1989;81:225-239.
22. Ahlborg UG, Becking GC, Birnbaum LC, et al. Toxic equivalency factors for dioxin-like PCBs. Chemosphere. 1994;28:1049-1067.
23. Nilsson S, Norlén BJ, Widmark A. A systematic overview of radiation therapy effects in prostate cancer. Acta Oncol. 2004;43:316-381.
24. Omoto, Y, Imamov O, Warner M, Gustafsson J-Å. Estrogen receptor α and imprinting of the neonatal mouse ventral prostate by estrogen. Proc Natl Acad Sci USA. 2005;102:1484-1489.
25. Hardell L, van Bavel B, Lindström G, et al. Increased concentrations of polychlorinated biphenyls, hexachlorobenzene, and chlordanes in mothers of men with testicular cancer. Environ Health Perspect. 2003;111:930-934.
26. Hardell L, van Bavel B, Lindström G, et al. Concentrations of polychlorinated biphenyls in blood and the risk for testicular cancer. Int J Androl. 2004;27:282-290.
27. Cancel-Tassin G, Cussenot O. Prostatate cancer genetics. Minerva Urol Nefrol. 2005;57:289-300.
28. Roach M, Lu J, Pilepich MV, et al. Long-term survival after radiotherapy: radiation therapy oncology group prostate cancer trials. J Urol. 1999;161:864-868.
29. Chodak GW, Thisted RA, Gerber GS, et al. Results of conservative management of clinically localized prostate cancer. N Engl J Med. 1994;330:242-248.